Trials / Completed
CompletedNCT03228342
Ultrasound Impact in Rheumatoid Arthritis Patient Reported Outcomes
The Impact of Musculoskeletal Ultrasound-added to Clinical Evaluations- on Patient Reported Outcomes: A Prospective Study of Rheumatoid Arthritis Patients Classified in Remission/Low Disease Activity (ULTRAPRO)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 94 (actual)
- Sponsor
- Clínica de Artritis Temprana · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the impact of MusculoSkeletal Ultrasound added to Rheumatoid Arthritis patients classified in remission/low disease activity in terms of Patient Reported Outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | MusculoSkeletal Ultrasound | Patient will be assess with ultrasound (GUS-7 score) and the results will be informed to his/her attending Rheumatologist. The Patient Reported Outcomes will be evaluated a 0,6 and 12 months after randomization. |
| DIAGNOSTIC_TEST | MusculoSkeletal Ultrasound | Patient will be assess with ultrasound (GUS-7 score) and the results will not be informed to his/her attending Rheumatologist. The Patient Reported Outcomes will be evaluated a 0,6 and 12 months after randomization. |
Timeline
- Start date
- 2017-05-03
- Primary completion
- 2019-01-28
- Completion
- 2019-01-28
- First posted
- 2017-07-24
- Last updated
- 2019-01-30
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT03228342. Inclusion in this directory is not an endorsement.